Literature DB >> 1215885

[Familial Wilson's disease: copper induced hemolysis, hypersplenism and hyperpigmentation as the main symptoms].

P Steiner, P Frey, G A Lupi, H J Kistler.   

Abstract

Wilson's disease was diagnosed in a 16-year-old adolescent who presented with signs of hypersplenism due to cirrhosis, with marked hyperpigmentation of both lower legs and neurological disturbances. In view of progressive thrombocytopenia and leukocytopenia, splenectomy was performed during therapy with penicillamine later in the course, and the result was good. The patient's 12-year-old sister was found to have a hepatic form of Wilson's disease with typical biochemical findings. During the initial hospitalization a severe, spontaneous copper-induced hemolysis was noted. Another sister probably has a presymptomatic form of the disease. The parents are healthy but heterozygote carriers with regard to biochemical findings. The importance is stressed of hypersplenism, hyperpigmentation of the legs and especially of acute hemolysis in infancy as pointers in the diagnosis of Wilson's disease. Further diagnostic and therapeutic aspects are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1215885

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  3 in total

1.  Wilson's disease in association with anetoderma.

Authors:  Irina Ivanova Ivanova; Iskren Andreev Kotzev; Maria Vassileva Atanassova; Diana Todorova Gancheva; Stoyan Ivanov Pavlov; Ivan Jordanov Krasnaliev; Dimitrina Hristova Konstantinova
Journal:  Clin J Gastroenterol       Date:  2015-01-24

2.  Generalized hyperpigmentation in Wilson's disease: An unusual association.

Authors:  Madhumita Nandi; Sumantra Sarkar; Rakesh Mondal
Journal:  J Neurosci Rural Pract       Date:  2013-01

3.  Successful Splenectomy for Hypersplenism in Wilson's Disease: A Single Center Experience from China.

Authors:  Liang-Yong Li; Wen-Ming Yang; Huai-Zhen Chen; Yun-Hu Wu; Xiang Fang; Jing Zhang; Zhen Wang; Yong-Sheng Han; Yu Wang
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.